Vaccines for Prevention of Meningococcal Disease

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 1989 Apr 1

PMID 2497956

Citations 40

Authors

C E Frasch

Affiliations

Soon will be listed here.

Citing Articles

Population coverage analysis of T-Cell epitopes of Neisseria meningitidis serogroup B from Iron acquisition proteins for vaccine design.

Misra N, Panda P, Shah K, Sukla L, Chaubey P Bioinformation. 2011; 6(7):255-61.

PMID: 21738325 PMC: 3124689. DOI: 10.6026/97320630006255.

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes.

E Baart G, Zomer B, de Haan A, van der Pol L, Beuvery E, Tramper J Genome Biol. 2007; 8(7):R136.

PMID: 17617894 PMC: 2323225. DOI: 10.1186/gb-2007-8-7-r136.

T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease.

Robinson K, Wooldridge K, Wells D, Hasan A, Todd I, Robins A Infect Immun. 2005; 73(8):4684-93.

PMID: 16040981 PMC: 1201220. DOI: 10.1128/IAI.73.8.4684-4693.2005.

Evidence of positive Darwinian selection in putative meningococcal vaccine antigens.

Fitzpatrick D, Creevey C, McInerney J J Mol Evol. 2005; 61(1):90-8.

PMID: 16007491 DOI: 10.1007/s00239-004-0290-6.

Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.

Miller M, Shahab C Pharmacoeconomics. 2005; 23(4):333-43.

PMID: 15853434 DOI: 10.2165/00019053-200523040-00004.

References

WILLIAMSON W, Greenwood B . Impairment of the immune response to vaccination after acute malaria. Lancet. 1978; 1(8078):1328-9. DOI: 10.1016/s0140-6736(78)92403-0. View

Saukkonen K, Abdillahi H, Poolman J, Leinonen M . Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb Pathog. 1987; 3(4):261-7. DOI: 10.1016/0882-4010(87)90059-3. View

Kayhty H, Karanko V, Peltola H, Sarna S, Makela P . Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis. 1980; 142(6):861-8. DOI: 10.1093/infdis/142.6.861. View

Tsai C, Frasch C, Mocca L . Five structural classes of major outer membrane proteins in Neisseria meningitidis. J Bacteriol. 1981; 146(1):69-78. PMC: 217053. DOI: 10.1128/jb.146.1.69-78.1981. View

Jennings H, Lugowski C . Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol. 1981; 127(3):1011-8. View

Beuvery E, Miedema F, van Delft R, Haverkamp J . Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines. Infect Immun. 1983; 40(1):39-45. PMC: 264815. DOI: 10.1128/iai.40.1.39-45.1983. View

Mandrell R, Zollinger W . Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins. J Immunol Methods. 1984; 67(1):1-11. DOI: 10.1016/0022-1759(84)90080-2. View

Ross S, Densen P . Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore). 1984; 63(5):243-73. View

Moreno C, Lifely M, Esdaile J . Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide. Infect Immun. 1985; 47(2):527-33. PMC: 263203. DOI: 10.1128/iai.47.2.527-533.1985. View

10.

Beuvery E, vd Kaaden A, Kanhai V, Leussink A . Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods. Vaccine. 1983; 1(1):31-6. DOI: 10.1016/0264-410x(83)90010-5. View

11.

Peltola H, Safary A, Kayhty H, Karanko V, Andre F . Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics. 1985; 76(1):91-6. View

12.

Reingold A, Broome C, Hightower A, AJELLO G, Bolan G, Adamsbaum C . Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet. 1985; 2(8447):114-8. DOI: 10.1016/s0140-6736(85)90224-7. View

13.

Moreno C, Lifely M, Esdaile J . Effect of aluminum ions on chemical and immunological properties of meningococcal group B polysaccharide. Infect Immun. 1985; 49(3):587-92. PMC: 261215. DOI: 10.1128/iai.49.3.587-592.1985. View

14.

Brodeur B, Larose Y, Tsang P, Hamel J, Ashton F, Ryan A . Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infect Immun. 1985; 50(2):510-6. PMC: 261984. DOI: 10.1128/iai.50.2.510-516.1985. View

15.

Wedege E, Froholm L . Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect Immun. 1986; 51(2):571-8. PMC: 262379. DOI: 10.1128/iai.51.2.571-578.1986. View

16.

Granoff D, Munson Jr R . Prospects for prevention of Haemophilus influenzae type b disease by immunization. J Infect Dis. 1986; 153(3):448-61. DOI: 10.1093/infdis/153.3.448. View

17.

Jennings H, Roy R, Gamian A . Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J Immunol. 1986; 137(5):1708-13. View

18.

LEPOW M, Beeler J, Randolph M, SAMUELSON J, Hankins W . Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children. J Infect Dis. 1986; 154(6):1033-6. DOI: 10.1093/infdis/154.6.1033. View

19.

Gotschlich E, Goldschneider I, Artenstein M . Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969; 129(6):1367-84. PMC: 2138657. DOI: 10.1084/jem.129.6.1367. View

20.

Artenstein M, Gold R, Zimmerly J, Wyle F, Schneider H, Harkins C . Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970; 282(8):417-20. DOI: 10.1056/NEJM197002192820803. View